Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C178323-50 50 µl $356 
LS-C178323-100 100 µl $461 
ACLY / ATP Citrate Lyase Antibody - Immunocytochemistry of HeLa cells using anti- ATP-Citrate Lyase (C-terminus) antibody diluted 1:150.
ACLY / ATP Citrate Lyase Antibody - ACLY (C-terminus) antibody at 1/1000 dilution Lane1: K562 whole cell lysate 40 ug/lane Lane2: HeLa whole cell lysate 40 ug/lane.
ACLY / ATP Citrate Lyase Antibody - Flow Cytometry analysis of HeLa cells stained with ATP-Citrate Lyase (red, 1/100 dilution), followed by FITC-conjugated goat anti-mouse IgG. Black line histogram represents the isotype control, normal mouse IgG.
ACLY / ATP Citrate Lyase Antibody - Immunocytochemistry of HeLa cells using anti- ATP-Citrate Lyase (C-terminus) antibody diluted 1:150.
ACLY / ATP Citrate Lyase Antibody - ACLY (C-terminus) antibody at 1/1000 dilution Lane1: K562 whole cell lysate 40 ug/lane Lane2: HeLa whole cell lysate 40 ug/lane.
ACLY / ATP Citrate Lyase Antibody - Flow Cytometry analysis of HeLa cells stained with ATP-Citrate Lyase (red, 1/100 dilution), followed by FITC-conjugated goat anti-mouse IgG. Black line histogram represents the isotype control, normal mouse IgG.
1 of 3
2 of 3
3 of 3

Monoclonal Mouse anti‑Human ACLY / ATP Citrate Lyase Antibody (C‑Terminus, IF, WB) LS‑C178323

Monoclonal Mouse anti‑Human ACLY / ATP Citrate Lyase Antibody (C‑Terminus, IF, WB) LS‑C178323

Antibody:
ACLY / ATP Citrate Lyase Mouse anti-Human Monoclonal (C-Terminus) Antibody
Application:
ICC, IF, WB, Flo
Reactivity:
Human
Format:
Unconjugated, Unmodified
Price
Catalog Number
$356
LS-C178323-50
Toll Free North America
206-374-1102
For Research Use Only

Overview

Antibody:
ACLY / ATP Citrate Lyase Mouse anti-Human Monoclonal (C-Terminus) Antibody
Application:
ICC, IF, WB, Flo
Reactivity:
Human
Format:
Unconjugated, Unmodified

Specifications

Description
ATP Citrate Lyase antibody LS-C178323 is an unconjugated mouse monoclonal antibody to human ATP Citrate Lyase (ACLY) (C-Terminus). Validated for Flow, ICC, IF and WB.
Target
Human ACLY / ATP Citrate Lyase
Synonyms
ACLY | ACL | ATP citrate synthase | ATPCL | ATP citrate lyase | ATP-citrate (pro-S-)-lyase | CLATP | ATP-citrate synthase | Citrate cleavage enzyme | Citrate Lyase
Host
Mouse
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
Monoclonal
Conjugations
Unconjugated
Purification
Affinity purified
Modifications
Unmodified
Immunogen
Synthetic peptide from C-Terminus of human ACLY / Citrate Lyase
Epitope
C-Terminus
Specificity
Human ACLY / Citrate Lyase
Applications
  • ICC
  • Immunofluorescence
  • Western blot
  • Flow Cytometry
Presentation
0.1M Tris-Glycine, pH 7.4, 150 mM NaCl, 0.2% sodium azide, 50% glycerol
Storage
Short term: store at 4°C. Long term: aliquot and store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About ACLY / ATP Citrate Lyase
P53396 NM_001096 NP_001087.2

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 4/19/2024